Reference priceBRL R$1,170.00Original source price: INR 18,000.00. Converted estimates are available by currency selection.
| Brand | INTAS PHARMACEUTICALS LTD |
|---|---|
| Manufacturer | Intas Pharmaceuticals Ltd. |
| Prescription required | Yes |
Bevatas 300mg Injection
Bevacizumab (300mg)
Description
Bevatas 300mg Injection is an anticancer medicine consisting of the active ingredient Bevacizumab. This medicine is developed to prevent the growth of tumors. It is indicated along with other chemotherapy drugs to treat metastatic breast cancer, brain cancer, cervical cancer, kidney cancer, lung cancer, and colorectal cancer. It is also used to treat cancers of the ovary, fallopian tube or primary peritoneal cancer. Use effective birth control during the treatment and for at least six months after the last dose. Bevatas 300mg Injection is not recommended for adolescents and children under the age of 18. Discuss with your doctor about the preservation of ovaries if you are planning for pregnancy in the near future as this medicine may cause fertility issues in women. It would be best to avoid breastfeeding your baby as this medicine may interfere with the growth and development.Benefits
Uses of Bevatas Solution for Infusion 1.Cancer of colon and rectum 2.Ovarian cancer 3.Cervical cancer 4.Kidney cancer 5.Brain tumor 5.Non-small cell lung cancerHow to Use
Your doctor or nurse will give you this medicine. Kindly do not self-administer.Specification
Your doctor or nurse will give you this medicine. Kindly do not self-administer.Side Effects
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them Common side effects of Bevatas Nosebleeds Headache High blood pressure Inflammation of the nose Protein in urine Taste change Dry skin Hemorrhage Increased lacrimation Back pain Exfoliative dermatitisEsta informação é apenas para referência. Consulte um profissional de saúde antes de usar qualquer medicamento.